company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3441000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,10000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1038000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2594000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1169000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9897000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,28139000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,679000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,21346000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,75699000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,773000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,99159000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,,totalassets,Total Assets,=,debit,usd,127977000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10628000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6814000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,889000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,13984000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42315000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,20114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1291000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,3137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,46907000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,71449000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,113764000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,8344000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,730987000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-682838000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5869000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5869000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5869000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,,2011-06-30,2012-02-10 17:01:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,127977000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2251000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,10000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1719000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1960000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1194000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9693000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,26817000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,678000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,20616000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72929000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,95663000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,,totalassets,Total Assets,=,debit,usd,123158000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10072000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7480000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,426000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,14476000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42454000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,20200000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1291000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,3184000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,44626000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,69301000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,111755000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,8344000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,731920000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-686581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,,2011-09-30,2012-02-10 17:02:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,123158000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1517000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1992000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1345000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8676000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,23544000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,375000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,14226000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,57744000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,563000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,86112000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,,totalassets,Total Assets,=,debit,usd,110031000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2936000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7893000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4143000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,727000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,11507000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27206000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,26435000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3370000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2372000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,32117000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,64294000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,91500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,741910000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-681099000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,18531000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,18531000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,18531000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,,2012-03-31,2012-11-14 14:01:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,110031000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8885000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,817000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2698000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6959000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,21096000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,644000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,9822000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,57162000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,524000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,81087000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,,totalassets,Total Assets,=,debit,usd,102827000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7306000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6746000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4228000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,412000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,12128000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30820000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,22211000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2722000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,27076000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,54529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,85349000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,743386000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-683628000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,17478000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,17478000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,17478000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,,2012-06-30,2012-11-14 14:03:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,102827000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7046000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2157000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2548000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5446000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17434000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,853000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,8644000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,56580000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,416000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,79219000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,,totalassets,Total Assets,=,debit,usd,97506000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10272000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6027000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5381000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,458000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7741000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,29879000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17876000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2538000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2662000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,23316000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,46392000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,76271000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,747337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-683822000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,21235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,21235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,21235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,,2012-09-30,2012-11-14 14:05:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,97506000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5037000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4622000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2838000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5243000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,17740000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,758000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3933000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,7916000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,55319000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,8000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,451000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,79865000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,,totalassets,Total Assets,=,debit,usd,98363000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13212000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5522000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4518000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,556000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7628000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33017000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5494000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2125000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,791000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,26340000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,34750000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67767000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,752973000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-681263000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1166000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,30596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,30596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,30596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q1,,2013-03-31,2013-05-08 16:09:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,98363000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5923000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,699000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2265000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5683000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,14570000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,804000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4162000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,8579000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,54245000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,8000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4965000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,84197000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,,totalassets,Total Assets,=,debit,usd,99571000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13600000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4755000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4021000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,452000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,8162000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32571000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1970000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,901000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,22776000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,27732000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60303000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,755326000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-675173000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1395000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,39268000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,39268000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,39268000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,,2013-06-30,2013-08-01 10:23:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,99571000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3271000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5507000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1838000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6019000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,16635000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,834000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4968000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,8387000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,53692000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,8000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4915000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,84208000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,,totalassets,Total Assets,=,debit,usd,101677000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12375000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4304000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4619000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,336000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,9246000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32461000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,962000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,21354000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24401000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56862000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,758102000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-673208000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-42280000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2201000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44815000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44815000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44815000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,,2013-09-30,2013-11-08 17:28:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,101677000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12977000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12275000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4673000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1949000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,33403000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,690000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,448000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,52505000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4846000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,71378000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,,totalassets,Total Assets,=,debit,usd,105471000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5769000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3675000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5451000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1574000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4536000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21005000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1151000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16229000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19465000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,40470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,723300000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-669242000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10943000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,65001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,65001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,65001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,,2014-03-31,2014-05-07 17:30:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,105471000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14537000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,7490000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3133000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,817000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2608000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,28585000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,619000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1261000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,413000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,51911000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4820000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,70643000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,,totalassets,Total Assets,=,debit,usd,99847000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2698000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3241000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,92000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1574000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5957000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18621000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1104000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,14951000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,18140000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,36761000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,726779000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-667650000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5041000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,64170000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,64170000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1084000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63086000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,,2014-06-30,2014-08-05 17:22:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,99847000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,180663000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,5925000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5812000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1071000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5049000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,198520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,551000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1261000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,51317000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4798000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3598000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,73212000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,,totalassets,Total Assets,=,debit,usd,272283000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4864000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4311000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1574000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7233000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18433000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,193631000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1214000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,14137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,211067000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,229500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,707200000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-666371000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3543000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44372000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44372000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1589000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,42783000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,,2014-09-30,2014-10-31 16:23:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,272283000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,165766000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,11459000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7423000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2821000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4244000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,191713000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,440000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,600000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,50129000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4926000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3177000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,71070000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,,totalassets,Total Assets,=,debit,usd,263223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,348000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7442000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4263000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,67000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,258000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5779000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18157000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,198219000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2797000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,9570000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,212671000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230828000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,684375000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-658561000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9334000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35148000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35148000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-2753000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,32395000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,,2015-03-31,2015-05-11 08:38:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,263223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,108238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,600000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,73371000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,5547000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5532000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,802000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2635000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,196725000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,405000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,33996000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,49535000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8899000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2964000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,107632000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,,totalassets,Total Assets,=,debit,usd,304762000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2708000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5629000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,300000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,9312000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17949000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,200567000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2083000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,3059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12051000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,217760000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,235709000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,692785000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-634997000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,11265000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,69053000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,69053000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,69053000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,,2015-06-30,2015-08-04 20:37:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,304762000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,93770000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,600000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,93528000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,5547000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5517000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1221000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,7517000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2624000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,210324000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,355000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,31826000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,48941000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,206423000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8846000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2747000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,311021000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,,totalassets,Total Assets,=,debit,usd,521700000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3143000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4156000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,34000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,8920000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16253000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,202951000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2083000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8232000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,213266000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,229519000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,697081000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-410458000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5558000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,292181000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,292181000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,292181000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,,2015-09-30,2015-11-09 17:26:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,521700000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31293000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,81908000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,4767000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11779000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1750000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1562000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,133059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,567000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,28118000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72997000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,212823000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,129777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8616000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,452331000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,,totalassets,Total Assets,=,debit,usd,585957000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2688000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3669000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5883000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12240000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,204653000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4468000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,209121000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,221361000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,783911000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-422883000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3568000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,364596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,364596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,364596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,,2016-03-31,2016-11-14 18:10:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,585957000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,86580000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37535000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,3207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6586000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4027000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2756000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,140691000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1826000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,17339000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72359000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,207435000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,133486000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27729000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,458348000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,,totalassets,Total Assets,=,debit,usd,600865000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,210115000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2757000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6675000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6584000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,226131000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230472000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,32138000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,762604000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-428001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3652000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,338255000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,338255000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,338255000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q3,,2016-09-30,2016-11-14 19:12:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,600865000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10641000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,148733000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7057000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7629000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,641000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,174701000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1898000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7262000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,3207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,201990000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,141007000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27451000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,453124000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,,totalassets,Total Assets,=,debit,usd,629723000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,215748000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6456000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4680000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,111000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,226995000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3950000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3950000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230945000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,26948000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,777123000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-408398000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3105000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,371830000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,371830000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,371830000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,,2017-03-31,2017-05-09 17:23:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,629723000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,112404000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,3207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13462000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6809000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1072000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,197177000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1875000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6014000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,199284000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,138837000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,24630000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,440972000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,,totalassets,Total Assets,=,debit,usd,640024000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,218630000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1799000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5325000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,86000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,225840000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4775000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4775000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,230615000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,24293000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,784397000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-402340000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3059000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,385116000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,385116000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,385116000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,,2017-06-30,2017-08-08 17:36:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,640024000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,32739000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,169520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,3007000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12816000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5007000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1112000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,224201000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3526000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,72207000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,196578000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,134939000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,25749000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,434610000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,,totalassets,Total Assets,=,debit,usd,662337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,221557000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3617000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6423000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,86000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,231683000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5891000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5891000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,237574000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,21597000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,793745000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-393914000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3335000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,403166000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,403166000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,403166000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,,2017-09-30,2017-11-09 16:08:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,662337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,51024000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,240864000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,3877000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,37108000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10531000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5647000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,349051000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4119000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,85961000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,225306000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,69368000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20863000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,401498000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,,totalassets,Total Assets,=,debit,usd,754668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,227547000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3407000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8480000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7545000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,246979000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7511000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10511000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,257490000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,16078000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,808786000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-327400000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-286000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,481100000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,481100000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,481100000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,,2018-03-31,2018-05-09 17:08:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,754668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,151459000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,865264000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,42001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,9520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,412226000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1480470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4187000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,85961000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,222001000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,44586000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,21079000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,373627000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,,totalassets,Total Assets,=,debit,usd,1858284000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,210370000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2682000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9312000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1700000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,408786000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,632850000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,595912000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,9709000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,605621000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1238471000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,874204000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-254240000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-151000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,619813000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,619813000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,619813000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,,2018-06-30,2018-08-08 17:17:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1858284000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,115560000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,43646000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,996311000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,46976000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,8136000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,534596000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1745225000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4407000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,85961000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,216276000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,32440000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,21433000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,356110000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,,totalassets,Total Assets,=,debit,usd,2105742000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,213144000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1647000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9267000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2450000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,566836000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,793344000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,602839000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10039000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,612878000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1406222000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,883498000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-183914000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-64000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,699520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,699520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,699520000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,,2018-09-30,2018-11-08 16:04:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2105742000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,105113000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1323575000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,26615000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11905000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,100687000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1567895000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5575000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,86809000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,216290000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,37419000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,340518000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,,totalassets,Total Assets,=,debit,usd,1913988000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,26756000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5061000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14771000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2808000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,113997000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,23384000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,186777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,616987000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,9614000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,20636000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,647237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,834014000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,643337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,437140000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-503000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1079974000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1079974000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1079974000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,,2019-03-31,2019-05-09 16:04:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1913988000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,273047000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1059002000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20259000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,9638000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,80361000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1442307000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6268000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,88000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,212609000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,52652000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,353261000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,,totalassets,Total Assets,=,debit,usd,1801836000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27087000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2888000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11540000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,939000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,47455000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,19076000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,108985000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,624209000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,694000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,26495000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,651398000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,760383000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,619274000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,422721000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-542000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1041453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1041453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1041453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,,2019-06-30,2019-08-08 16:12:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1801836000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,225302000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,874383000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21958000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6565000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,54895000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1183103000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6411000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,93513000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,216268000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,48181000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,357962000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,,totalassets,Total Assets,=,debit,usd,1547476000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2040000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13060000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2230000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,16571000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1794000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,35695000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,631533000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,3761000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25906000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,661200000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,696895000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,444604000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,407470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1493000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,850581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,850581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,850581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,,2019-09-30,2019-11-08 16:05:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1547476000.0
